Category: Biotech

Clinical Study Commemorative with Embedded Vial

Custom Lucite, with embedded vial, marking a clinical study of a cancer immunotherapy treatment. (22AZH090)

1 Image

Crystal Biotech Offering Deal Tombstone

Crystal deal tombstone, featuring a cube on a cut-corner, commemorating a follow-on offering by Turning Point Therapeutics. (21alj013)

1 Image

Curved Lucite Biopharma Deal Toy

Curved Lucite deal toy recognizing the merger of Statera Biopharma and Cleveland BioLabs. (21AKL364)

1 Image

Biotech Credit Facility Deal Toy

Crystal deal toy recognizing a credit facility provided to Vera Therapeutics. The California-based biotech company focuses on severe immunological diseases. (25ALJ191)

1 Image

Lucite Lab Beaker Deal Toy

Lucite deal toy commemorating financing provided to ITM, a Munich-based biotech company. (25ALJ200)

1 Image

Biopharma Public Offering Tombstone

Crystal financial tombstone marking a public offering by Cellectar Biosciences. The New Jersey-based company will use the proceeds to fund a clinical study of a breast cancer drug. (25AKL244)

1 Image

NF1 FDA Approval Commemorative

Custom crystal commemorating FDA approval of Gomekli, a treatment for the rare tumor disease ncurofibromatosis 1 (NF1). (25AZH094)

2 Images
Side view of crystal commemorative marking approval by the Food and Drug Administration (FDA) of a tumor treatment.

Eye-Themed Crystal Deal Toy

Crystal deal toy commemorating a follow-on stock offering by Oculis. The Swiss biopharmaceutical company provides treatment for eye conditions such as diabetic macula edema and acute optic neuritis. (25AKL187)

1 Image

Cancer Therapy First-in-Human Lucite Commemorative

Custom Lucite, incorporating an embedded vial, celebrating the first-in-human dosing in a Phase 1 clinical trial of cancer treatment developed by biotech company Immunome. (25ALJ040)

2 Images
Back view of a custom Lucite with an embedded vial marking the first patient dosed with a cancer therapy.